BlackRock Japan’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-90,983
Closed -$6.17M 1312
2016
Q3
$6.17M Buy
90,983
+1,229
+1% +$83.3K 0.02% 618
2016
Q2
$4.98M Buy
89,754
+181
+0.2% +$10K 0.02% 637
2016
Q1
$5.62M Sell
89,573
-346
-0.4% -$21.7K 0.02% 613
2015
Q4
$8.47M Sell
89,919
-47
-0.1% -$4.43K 0.03% 548
2015
Q3
$7.23M Sell
89,966
-3,760
-4% -$302K 0.03% 566
2015
Q2
$11.2M Buy
+93,726
New +$11.2M 0.04% 463
2014
Q3
Sell
-1,070
Closed -$68K 1249
2014
Q2
$68K Sell
1,070
-1,240
-54% -$78.8K ﹤0.01% 997
2014
Q1
$155K Buy
+2,310
New +$155K ﹤0.01% 989